Bharat Biotech’s corona vaccine Covaccine may get emergency use approval from the World Health Organization (WHO) later this month. WHO’s Chief Scientist Dr. Soumya Swaminathan said on Sunday that a meeting of the WHO’s Technical Advisory Group will be held on October 26 to consider the Emergency Use (EUL) of Kovaxin, the Kovid-19 vaccine of Hyderabad-based Bharat Biotech.
Dr Soumya Swaminathan said…
Giving information about this on Twitter, Swaminathan also said that WHO is working with Bharat Biotech for this. We aim to expand access to a broader portfolio of vaccines approved for emergency use and everywhere. Earlier in the month, the WHO tweeted that the vaccine was providing data to the WHO on an ongoing basis, and on 27 September provided additional information at its request. Experts are currently reviewing this information and see if it helps. If the questions are answered, the WHO’s assessment will be finalized next week.
Play fantasy cricket online and earn real cash
The vaccine was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
According to the manufacturers, Covacin was found to be 77.8 percent effective in Phase-3 clinical trials. India is using three vaccines in the vaccination campaign against corona infection. One of them is Covishield from Serum Institute of India and the other is Covaxin from Bharat Biotech. In addition, the Russian vaccine Sputnik V is the third vaccine that has received emergency use approval from the Drug Controller General of India (DGCI) for emergency use.
stages of vaccination
Vaccination started in the country from 16 January. Health workers and frontline workers were first vaccinated. The second phase of the vaccination campaign started on 1 March 2021. During this time vaccination of people above 60 years and above 45 years against serious disease started. On April 1, 2021, it was further relaxed for all people above 45 years. The third phase started on May 1, 2021. All people above the age of 18 are approved for vaccination.
.